AGBL Abyssinia is now fully operational and ready to deliver novel biomedical products and technologies) to the Ethiopian and Northeast African market.
“Ethiopia’s central location, large population and abundant resources, allied to its rich history and stable social policies make it strategically important for AGBL to have presence in this pivotal market”; says Dr. Nassim-Marie Hambouz, Director of commercial operations at AGBL
The AGBL Abyssinia launch event took place at the Addis Ababa Hyatt Regency and was attended by HE Jemal Beker, State Minister for Innovation and Technology, Dr. Kassahun Tesfaye, Director General of the Ethiopian Biotechnology Institute (EBTi), Dr Tamer Degheidy, AGBL Chief Executive Officer, Rodolphe Vetchenou, Illumina Executive Territory Manager, and other dignitaries.
AGBL Keynote speakers addressed corporate overview of the AGBL Group, Next Generation Sequencing solutions and introduced the audience to Illumina’s benchtop sequencer; the iSeq 100 system. AGBL also celebrated the establishment of its training Lab at Ethiopian Biotechnology institute (EBTi) and there was an official signing of the MoU between AGBL and EBTi.
Check out the Press Release http://bit.ly/2PQ7wO5